Connection
Jennifer Diamond to Aromatase Inhibitors
This is a "connection" page, showing publications Jennifer Diamond has written about Aromatase Inhibitors.
|
|
| |
Connection Strength |
|
 |
|
 |
| |
0.515 |
|
|
|
-
Leach HJ, Bolt M, Clark EW, Hull SE, Diamond JR, Lyden K, Scalzo RL. Cardiorespiratory Fitness, Physical Activity, Sedentary Behavior, and Diabetes Risk Among Breast Cancer Survivors Treated with Endocrine Therapies. Med Sci Sports Exerc. 2026 Jan 01; 58(1):70-77.
Score: 0.231
-
Weiss J, Afghahi A, Shagisultanova E, Diamond JR. Approaching Use of CDK4/6 Inhibitors in Metastatic HR+, HER2- Breast Cancer. Oncology (Williston Park). 2018 Oct 15; 32(10):513-5.
Score: 0.143
-
Stoen E, Kabos P, Borden KC, Brown RJ, Borges VF, Diamond JR. A 35-Year-Old Woman With a Change in HER2 Expression Following Neoadjuvant Chemotherapy for Invasive Breast Cancer. Oncology (Williston Park). 2018 06; 32(6):298-302.
Score: 0.140